Richard E. Ringel

Richard E. Ringel

Auto-generated profile, based on publicly available information

Richard E. Ringel

Division of Pediatric Cardiology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
RHRalf J. Holzer
Ralf J. Holzer
KGKimberlee Gauvreau
Kimberlee Gauvreau
KMKerry McEnaney
Kerry McEnaney
HWHanano Watanabe
Hanano Watanabe
RRRichard Ringel
Richard Ringel
Background: Long-term outcome data of stent-implantation for coarctation of the aorta are limited. We report up to 5 years of postimplant follow-up in patients enrolled into the COAST (Coarctation of the Aorta Stent Trial) and the COAST II trial (Covered Cheatham-Platinum Stents for Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta), evaluating the bare and Covered Cheatham-Platinum Stents for the treatment of coarctation of the aorta and associated aortic wall injury. Methods: Data was prospectively collected during the 2 multi-center studies, enrolling 248 patients (COAST: n=121, COAST II: n=127). Late follow-up data (48–60 month) was compared with immediate (1 month) and early (12 months) follow-up. Results: There was a notable decrease in the use of antihypertensive medication, from 53% at immediate, to 42% at early, and 29% at late follow-up. The cumulative incidence of stent fractures was 0% immediately, 2.9% at early, and 24.4% at late follow-up. Independent predictors for stent fractures at late follow-up were age <18 years, male sex, minimum stent diameter ≥12 mm, and use of bare metal stent. The cumulative incidence of reintervention was 1.6% at immediate, 5.1% at early, and 21.3% at late follow-up. Independent predictors for reinterventions at late follow-up were age <18 years, post implantation systolic arm-leg blood pressure gradient ≥10 mm Hg, minimum stent diameter at implantation <12 mm, and initial coarctation minimum diameter <6 mm. There were 13 patients with aortic aneurysms, with a cumulative incidence of 6.3% at late follow-up. Conclusions: Coarctation stenting is effective at maintaining obstruction relief up to 60 months postimplant with reduction in the number of patients requiring antihypertensive medication. However, an increase in-stent fractures and reinterventions were observed between medium and long-term follow-up. Covered stents appear to confer some protection from the development of stent fractures but do not provide complete protection from late aneurysm formation. Registration: URL: https://www.clinicaltrials.gov ; Unique identifiers: NCT00552812 and NCT01278303.

1 April 2003 in The American Journal of Cardiology
Verified
Journal Article
Closed access
RRRichard E Ringel
Richard E Ringel
SPStacie B Peddy
Stacie B Peddy

15 May 2013 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
RRRichard E. Ringel
Richard E. Ringel
JVJulie Vincent
Julie Vincent
KJKathy J. Jenkins
Kathy J. Jenkins
KGKimberlee Gauvreau
Kimberlee Gauvreau
HMHeidi Moses
Heidi Moses
KUKudret Usmani
Kudret Usmani

1 July 2012 in American Heart Journal
Verified
Journal Article
Closed access
RRRichard E. Ringel
Richard E. Ringel
KGKimberlee Gauvreau
Kimberlee Gauvreau
HMHeidi Moses
Heidi Moses
KJKathy J. Jenkins
Kathy J. Jenkins

7 October 2014 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
RBRam N. Bishnoi
Ram N. Bishnoi
TJThomas K. Jones
Thomas K. Jones
JKJacqueline Kreutzer
Jacqueline Kreutzer
RRRichard E. Ringel
Richard E. Ringel

5 June 2018 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
RFRyan Felling
Ryan Felling
RRRichard E. Ringel
Richard E. Ringel